Najat Khan - 16 Apr 2024 Form 3 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Director
Signature
/s/Jonathan Golightly, attorney-in-fact
Issuer symbol
RXRX
Transactions as of
16 Apr 2024
Net transactions value
$0
Form type
3
Filing time
25 Apr 2024, 17:08:02 UTC
Next filing
05 Aug 2024

No securities are beneficially owned.